Activated CTLs kill target tumor cells mainly through two pathways [39–41]: first, CTL release perforin (PFN) to transport secreted granzymes A and B (GzmA and GzmB) into tumor cells after forming pores in the tumor cell membrane, triggering an enzyme chain reaction that leads to apoptosis of tumor cells. The gene discussed is GZMB; the disease is neoplasm.